Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Frontiers in Immunology
|
November 25, 2022
Transcriptomic analysis of graft liver provides insight into the immune response of rat liver transplantation
Wanyue Cao, Jing Lu, Shanbao Li, et al.
Oncotargets and Therapy
|
March 19, 2019
Elevated <i>HOXA13</i> expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2
Zhiwei Qin, Zhengqian Chen, Junyong Weng, et al.
Frontiers in Genetics
|
December 5, 2022
Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer
Zhonglin Zhu, Qiuyan Zhao, Shanbao Li, et al.
Cancer Letters
|
March 23, 2024
LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3
Zhonglin Zhu, Minghan Li, Junyong Weng, et al.
Journal of Hematology & Oncology
|
July 16, 2022
Exploring immunotherapy in colorectal cancer
Junyong Weng, Shanbao Li, Zhonglin Zhu, et al.
Cancer Medicine
|
June 19, 2023
Cuproptosis-related miRNAs signature and immune infiltration characteristics in colorectal cancer
Zhonglin Zhu, Tianan Guo, Junyong Weng, et al.
Cell Death & Disease
|
June 14, 2020
Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression
Shanbao Li, Junyong Weng, Fangbin Song, et al.
Frontiers in Immunology
|
October 17, 2022
A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer
Zhonglin Zhu, Qiuyan Zhao, Wang Song, et al.
Translational Oncology
|
May 13, 2026
An ac4C-CDK4 regulatory axis driven by NAT10 sustains proliferative signaling in colorectal cancer
Jun Qin, Ye Shen, Shanbao Li, et al.
Oncotargets and Therapy
|
October 19, 2017
ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy
Fangbin Song, Jianbing Zhang, Shanbao Li, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Frontiers in Immunology
|
November 25, 2022
Transcriptomic analysis of graft liver provides insight into the immune response of rat liver transplantation
Wanyue Cao, Jing Lu, Shanbao Li, et al.
Oncotargets and Therapy
|
March 19, 2019
Elevated <i>HOXA13</i> expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2
Zhiwei Qin, Zhengqian Chen, Junyong Weng, et al.
Frontiers in Genetics
|
December 5, 2022
Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer
Zhonglin Zhu, Qiuyan Zhao, Shanbao Li, et al.
Cancer Letters
|
March 23, 2024
LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3
Zhonglin Zhu, Minghan Li, Junyong Weng, et al.
Journal of Hematology & Oncology
|
July 16, 2022
Exploring immunotherapy in colorectal cancer
Junyong Weng, Shanbao Li, Zhonglin Zhu, et al.
Cancer Medicine
|
June 19, 2023
Cuproptosis-related miRNAs signature and immune infiltration characteristics in colorectal cancer
Zhonglin Zhu, Tianan Guo, Junyong Weng, et al.
Cell Death & Disease
|
June 14, 2020
Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression
Shanbao Li, Junyong Weng, Fangbin Song, et al.
Frontiers in Immunology
|
October 17, 2022
A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer
Zhonglin Zhu, Qiuyan Zhao, Wang Song, et al.
Translational Oncology
|
May 13, 2026
An ac4C-CDK4 regulatory axis driven by NAT10 sustains proliferative signaling in colorectal cancer
Jun Qin, Ye Shen, Shanbao Li, et al.
Oncotargets and Therapy
|
October 19, 2017
ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy
Fangbin Song, Jianbing Zhang, Shanbao Li, et al.
Page
of 3